Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The Study of Men Born in 1933

Journal of Internal Medicine

Volumn 239, Issue 6, 1996, Pages 499-507

  Rosengren, Annika ^a   Wilhelmsen, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary disease; Fibrinogen; Population study; Smoking

Indexed keywords

FIBRINOGEN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SWEDEN;

EID: 0030012928     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.485821000.x     Document Type: Article

References (38)

1. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
2. Eriksson H, Wilhelmsen L, Welin L, Larsson B, Svärdsudd K, Tibblin G. 21-year follow-up of CHD and total mortality among men born in 1913. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen - A New CHD Risk Factor. Vienna: Blackwell-MZV, 1992.
3. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson GD. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
4. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
5. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987; 113: 1006-10.
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-6.
7. Stone MC, Thorp JM. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-9.
8. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-44.
9. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
10. Carlson LA, Böttiger LE, Åhfeldt PE. Risk factors for myocardial infarction in the Stockholm Prospective Study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979; 206: 351-60.
11. Kannel WB, D'Agostino RB, Belanger AJ. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 1992; 2: 457-66.
12. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G et al. Report on the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046-60.
13. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-63.
14. Ernst E. Plasma fibrinogen - an independent cardiovascular risk factor. J Intern Med 1990; 227: 365-72.
15. Moller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscl Thromb 1991; 11: 344-50.
16. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
17. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol 1990; 43: 913-19.
18. Dotevall A, Johansson S, Wilhelmsen L. Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Göteborg MONICA survey 1985. Ann Epidemiol 1994; 4: 369-74.
19. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson A-C, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. Br Med J 1990; 300: 634-8.
20. Rosengren A, Orth-Gomér K, Wilhelmsen L. Fibrinogen - a link between social support and coronary heart disease? In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen - A New CHD Risk Factor. Vienna: Blackwell-MZV, 1992.
21. Clauss A. Gerinnungsphysiologische Schnellmethode Zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
22. Statistics Sweden. Swedish Socio-economic Classification. Stockholm: Statistics Sweden, 1982.
23. Rosengren A, Orth-Gomér K, Wedel H, Wilhelmsen L. Stressful life events, social support, and mortality in men born in 1933. Br Med J 1993; 307: 1102-5.
24. Undén A-L, Orth-Gomér K. Development of a social support instrument for use in population surveys. Soc Sci Med 1989; 29: 1387-92.
25. Orth-Gomér K, Rosengren A, Wilhelmsen L. Lack of social support and incidence of coronary heart disease in middle aged Swedish men. Psychosomatic Medicine 1993; 55: 37-43.
26. Elmfeldt D, Wilhelmsen L, Tibblin G, Vedin A, Wilhelmsson C, Bengtsson C. Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis 1975; 28: 173-86.
27. The SAS Institute. SAS User's Guide: Statistics Version 608. Cary, North Carolina: SAS Institute, 1993.
28. Qizilbash N, Jones L, Warlow L, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic strokes. Br Med J 1991; 303: 605-9.
29. Ramley A, Smith FB, Fowkes FGR, Donnan PT, Housley E, Lowe GDO. Fibrinogen, peripheral arterial disease and smoking habit. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen - A New CHD Risk Factor. Vienna: Blackwell-MZV, 1992.
30. Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP. Plasma fibrinogen: levels and correlates in young adults. Am J Epidemiol 1993; 138: 1023-6.
31. Markowe HLJ, Marmot MG, Shipley MJ, Bulpitt CJ, Meade TW, Stirling Y, Vickers MV, Semmence A. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J 1985; 291: 1312-14.
32. Wilson TW, Kaplan GA, Kauhanen J, Cohen RD, Wu M, Salonen R, Salonen JT. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Epidemiol 1993; 137: 292-300.
33. Lowe GDO, Kweider M, Murray GD, Kinane D, McGowan DA. Fibrinogen and dental disease - a coronary risk factor. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen - A New CHD Risk Factor. Vienna: Blackwell-MZV, 1992.
34. Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D. Nonparticipants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand 1987; 221: 243-51.
35. Meade TW. Thrombosis and cardiovascular disease. Ann Epidemiol 1992; 2: 353-64.
36. Hagman M, Wilhelmsen L, Pennert K, Wedel H. Risk factors for angina pectoris in a population study of Swedish men. J Chronic Dis 1987; 40: 265-75.
37. Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 69: 338-42.
38. Bolibar I, Kienast J, Thompson SG, Matthias R, Niessner H, Fechtrup C. Relation of fibrinogen to presence and severity of coronary heart disease is independent of other heart disease. Am Heart J 1993; 125: 1601-5.